Exploring the resistance mechanism of triple-negative breast cancer to paclitaxel through the scRNA-seq analysis

紫杉醇 三阴性乳腺癌 乳腺癌 癌症研究 抗药性 生物 癌症 计算生物学 医学 肿瘤科 遗传学
作者
Wei Gao,Linlin Sun,Jinwei Gai,Yinan Cao,Shuqun Zhang
出处
期刊:PLOS ONE [Public Library of Science]
卷期号:19 (1): e0297260-e0297260 被引量:2
标识
DOI:10.1371/journal.pone.0297260
摘要

Background The triple negative breast cancer (TNBC) is the most malignant subtype of breast cancer with high aggressiveness. Although paclitaxel-based chemotherapy scenario present the mainstay in TNBC treatment, paclitaxel resistance is still a striking obstacle for cancer cure. So it is imperative to probe new therapeutic targets through illustrating the mechanisms underlying paclitaxel chemoresistance. Methods The Single cell RNA sequencing (scRNA-seq) data of TNBC cells treated with paclitaxel at different points were downloaded from the Gene Expression Omnibus (GEO) database. The Seurat R package was used to filter and integrate the scRNA-seq expression matrix. Cells were further clustered by the FindClusters function, and the gene marker of each subset was defined by FindAllMarkers function. Then, the hallmark score of each cell was calculated by AUCell R package, the biological function of the highly expressed interest genes was analyzed by the DAVID database. Subsequently, we performed pseudotime analysis to explore the change patterns of drug resistance genes and SCENIC analysis to identify the key transcription factors (TFs). Finally, the inhibitors of which were also analyzed by the CTD database. Results We finally obtained 6 cell subsets from 2798 cells, which were marked as AKR1C3+, WNT7A+, FAM72B+, RERG+, IDO1+ and HEY1+HCC1143 cell subsets, among which the AKR1C3+, IDO1+ and HEY1+ cell subsets proportions increased with increasing treatment time, and then were regarded as paclitaxel resistance subsets. Hallmark score and pseudotime analysis showed that these paclitaxel resistance subsets were associated with the inflammatory response, virus and interferon response activation. In addition, the gene regulatory networks (GRNs) indicated that 3 key TFs (STAT1, CEBPB and IRF7) played vital role in promoting resistance development, and five common inhibitors targeted these TFs as potential combination therapies of paclitaxel were identified. Conclusion In this study, we identified 3 paclitaxel resistance relevant IFs and their inhibitors, which offers essential molecular basis for paclitaxel resistance and beneficial guidance for the combination of paclitaxel in clinical TNBC therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
烟花应助tao采纳,获得10
2秒前
完美世界应助孟一采纳,获得30
3秒前
奚斌完成签到,获得积分10
4秒前
彭于晏应助vigour采纳,获得10
4秒前
研友_VZG7GZ应助关尔匕禾页采纳,获得10
5秒前
科研通AI5应助火星上念梦采纳,获得10
5秒前
聪明无敌小腚宝完成签到,获得积分10
6秒前
虚心求学完成签到,获得积分10
6秒前
Owen应助<小天才>采纳,获得10
9秒前
英姑应助九思采纳,获得10
10秒前
11秒前
11秒前
11秒前
12秒前
量子星尘发布了新的文献求助10
13秒前
JamesPei应助机灵的囧采纳,获得10
14秒前
llll发布了新的文献求助10
14秒前
orixero应助xmh采纳,获得10
14秒前
wq1020发布了新的文献求助10
16秒前
17秒前
皮皮蛙完成签到,获得积分10
17秒前
情怀应助常芹采纳,获得10
18秒前
肖肖发布了新的文献求助10
18秒前
18秒前
18秒前
19秒前
缥缈问柳完成签到,获得积分10
19秒前
19秒前
明理念桃完成签到,获得积分10
20秒前
13333发布了新的文献求助10
21秒前
Ava应助不吃意面的老番茄采纳,获得10
23秒前
23秒前
zhao完成签到 ,获得积分10
25秒前
26秒前
26秒前
26秒前
xmh完成签到,获得积分10
27秒前
什么也难不倒我完成签到 ,获得积分10
27秒前
28秒前
孟一发布了新的文献求助30
28秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988838
求助须知:如何正确求助?哪些是违规求助? 3531250
关于积分的说明 11252914
捐赠科研通 3269838
什么是DOI,文献DOI怎么找? 1804820
邀请新用户注册赠送积分活动 881943
科研通“疑难数据库(出版商)”最低求助积分说明 809028